Journal
Journal of Clinical Medicine
Publication Date
10-5-2022
Volume
11
Issue
19
First Page
5882
Document Type
Open Access Publication
DOI
10.3390/jcm11195882
Rights and Permissions
Hoertel, N.; Sánchez-Rico, M.; Kornhuber, J.; Gulbins, E.; Reiersen, A.M.; Lenze, E.J.; Fritz, B.A.; Jalali, F.; Mills, E.J.; Cougoule, C.; Carpinteiro, A.; Mühle, C.; Becker, K.A.; Boulware, D.R.; Blanco, C.; Alvarado, J.M.; Strub-Wourgaft, N.; Lemogne, C.; Limosin, F.; on behalf of AP-HP/Université Paris Cité/INSERM COVID-19 Research Collaboration, AP-HP COVID CDR Initiative and “Entrepôt de Données de Santé” AP-HP Consortium. Antidepressant Use and Its Association with 28-Day Mortality in Inpatients with SARS-CoV-2: Support for the FIASMA Model against COVID-19. J. Clin. Med. 2022, 11, 5882. https://doi.org/10.3390/jcm11195882 This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Recommended Citation
Hoertel, Nicolas; Reiersen, Angela M; Lenze, Eric J; Fritz, Bradley A; and et al., "Antidepressant use and its association with 28-day mortality in inpatients with SARS-CoV-2: Support for the FIASMA model against COVID-19." Journal of Clinical Medicine. 11, 19. 5882 (2022).
https://digitalcommons.wustl.edu/oa_4/930
Additional Links
Supplemental material is available for this article at publisher site.
